Russell J. Sheldon

799 total citations
30 papers, 664 citations indexed

About

Russell J. Sheldon is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Russell J. Sheldon has authored 30 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 12 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Russell J. Sheldon's work include Neuropeptides and Animal Physiology (11 papers), Pain Mechanisms and Treatments (6 papers) and Regulation of Appetite and Obesity (6 papers). Russell J. Sheldon is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Pain Mechanisms and Treatments (6 papers) and Regulation of Appetite and Obesity (6 papers). Russell J. Sheldon collaborates with scholars based in United States, Netherlands and Canada. Russell J. Sheldon's co-authors include Frank Porreca, Richard T. Hinkle, Robert J. Isfort, L. Nunan, David B. Cody, F. Porreca, Brian K. Kobilka, Thomas F. Burks, Qi Jiang and Qi Jiang and has published in prestigious journals such as Gastroenterology, Journal of Applied Physiology and Endocrinology.

In The Last Decade

Russell J. Sheldon

30 papers receiving 639 citations

Peers

Countries citing papers authored by Russell J. Sheldon

Since Specialization

Citations

This map shows the geographic impact of Russell J. Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell J. Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell J. Sheldon more than expected).

Fields of papers citing papers by Russell J. Sheldon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell J. Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell J. Sheldon. The network helps show where Russell J. Sheldon may publish in the future.

Co-authorship network of co-authors of Russell J. Sheldon

This figure shows the co-authorship network connecting the top 25 collaborators of Russell J. Sheldon. A scholar is included among the top collaborators of Russell J. Sheldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell J. Sheldon. Russell J. Sheldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Xinrong Tian, Rajesh Mishra, (unknown), Xiaoyan Hu, Nick Kim, Artur Mazur, Frank H. Ebetino, John A. Wos, (unknown), (unknown), (unknown), Russell J. Sheldon	19
2	Synthesis of Tic-d-Phe Ψ[CH2–CH2] isostere and its use in the development of melanocortin receptor agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Xinrong Tian, Xuemei Chen, (unknown), (unknown), (unknown), (unknown), Frank H. Ebetino, John A. Wos, (unknown), (unknown), (unknown), Russell J. Sheldon	11
3	Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force 2005 ·Journal of Applied Physiology ·Richard T. Hinkle, Elizabeth Donnelly, David B. Cody, Russell J. Sheldon, Robert J. Isfort	14
4	Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force 2004 ·Journal of Muscle Research and Cell Motility ·Richard T. Hinkle, Elizabeth Donnelly, David B. Cody, Mary Beth Bauer, Russell J. Sheldon, Robert J. Isfort	19
5	Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII 2003 ·International Journal of Obesity ·S.C. Benoit, Russell J. Sheldon, Ellen L. Air, (unknown), (unknown), (unknown), (unknown), (unknown), Charles C. McOsker, Stephen C. Woods, Randy J. Seeley	13
6	Activation of the CRF 2 receptor modulates skeletal muscle mass under physiological and pathological conditions 2003 ·American Journal of Physiology-Endocrinology and Metabolism ·Richard T. Hinkle, Elizabeth Donnelly, David B. Cody, Steven J. Samuelsson, (unknown), Mary Beth Bauer, Mark A. Tarnopolsky, Russell J. Sheldon, Sarah C. Coste, (unknown), Mary P. Stenzel‐Poore, Robert J. Isfort	24
7	Magnetic resonance imaging of denervation‐induced muscle atrophy: Effects of clenbuterol in the rat 2001 ·Muscle & Nerve ·Michael D. Cockman, Melissa B. Jones, (unknown), Russell J. Sheldon	10
8	Proteomic analysis of the atrophying rat soleus muscle following denervation 2000 ·Electrophoresis ·Robert J. Isfort, Richard T. Hinkle, Melissa B. Jones, (unknown), Kenneth D. Greis, Yiping Sun, T. Keough, N. Leigh Anderson, Russell J. Sheldon	50
9	Gastrointestinal motor effects of corticotropin-releasing factor in mice 1990 ·Regulatory Peptides ·Russell J. Sheldon, Qi Jiang, Frank Porreca, Laurel A. Fisher	39
10	Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Qi Jiang, Russell J. Sheldon, Frank Porreca	12
11	Effects of bombesin on mucosal ion transport in the mouse isolated jejunum. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Pierre Rivière, Russell J. Sheldon, (unknown), Thomas F. Burks, Frank Porreca	3
12	Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Qi Jiang, Julius S. Heyman, Russell J. Sheldon, (unknown), Frank Porreca	40
13	Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Russell J. Sheldon, L. Nunan, F. Porreca	36
14	Sites of clonidine action to inhibit gut propulsion in mice: Demonstration of a central component 1988 ·Gastroenterology ·Qi Jiang, Russell J. Sheldon, Frank Porreca	20
15	In vivo protection against soman toxicity by known inhibitors of acetylcholine synthesis in vitro 1988 ·Biochemical Pharmacology ·Gerald H. Sterling, (unknown), Russell J. Sheldon, J. J. O’Neill	12
16	Central and Peripheral Visceral Effects of Bombesin 1988 ·Annals of the New York Academy of Sciences ·Frank Porreca, Thomas F. Burks, Russell J. Sheldon	4
17	U50,488H differentially antagonizes the bladder effects of μ agonists at spinal sites 1988 ·European Journal of Pharmacology ·Russell J. Sheldon, L. Nunan, Frank Porreca	17
18	A comparison of the central gastrointestinal antitransit effects of morphine and bombesin in the mouse 1987 ·Life Sciences ·Qi Jiang, Russell J. Sheldon, Frank Porreca	3
19	Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·Russell J. Sheldon, L. Nunan, F. Porreca	37
20	In vivo and in vitro studies with agents that cause quasi-morphine withdrawal syndromes 1982 ·Life Sciences ·Russell J. Sheldon, Alan Cowan	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact